These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31845844)

  • 1. Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma.
    Park JE; Kim HS; Park SY; Nam SJ; Chun SM; Jo Y; Kim JH
    Radiology; 2020 Feb; 294(2):388-397. PubMed ID: 31845844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
    Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
    Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
    Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DTI-based radiomics model for predicting epidermal growth factor receptor (EGFR) amplification in adult IDH1-wild glioblastomas.
    Wang D; Han Q; Yang S; Cui J; Xia W; Lu Y; Yin B; Geng D
    Acta Radiol; 2024 Oct; 65(10):1291-1299. PubMed ID: 39411882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status.
    Park CJ; Choi YS; Park YW; Ahn SS; Kang SG; Chang JH; Kim SH; Lee SK
    Neuroradiology; 2020 Mar; 62(3):319-326. PubMed ID: 31820065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-Stage Training Framework Using Multicontrast MRI Radiomics for
    Truong NCD; Bangalore Yogananda CG; Wagner BC; Holcomb JM; Reddy D; Saadat N; Hatanpaa KJ; Patel TR; Fei B; Lee MD; Jain R; Bruce RJ; Pinho MC; Madhuranthakam AJ; Maldjian JA
    Radiol Artif Intell; 2024 Jul; 6(4):e230218. PubMed ID: 38775670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
    Sohn B; Park K; Ahn SS; Park YW; Choi SH; Kang SG; Kim SH; Chang JH; Lee SK
    J Neurooncol; 2023 Sep; 164(2):341-351. PubMed ID: 37689596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
    Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
    Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.
    Su X; Sun H; Chen N; Roberts N; Yang X; Wang W; Li J; Huang X; Gong Q; Yue Q
    Clin Radiol; 2020 Dec; 75(12):963.e7-963.e15. PubMed ID: 32921406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.
    Xing Z; Huang W; Su Y; Yang X; Zhou X; Cao D
    Clin Radiol; 2022 Aug; 77(8):e576-e584. PubMed ID: 35469666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application value of support vector machine model based on multimodal MRI in predicting IDH-1mutation and Ki-67 expression in glioma.
    Liang HX; Wang ZY; Li Y; Ren AN; Chen ZF; Wang XZ; Wang XM; Yuan ZG
    BMC Med Imaging; 2024 Sep; 24(1):244. PubMed ID: 39285364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
    Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
    Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.
    Choi KS; Choi SH; Jeong B
    Neuro Oncol; 2019 Sep; 21(9):1197-1209. PubMed ID: 31127834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI.
    Pak E; Choi KS; Choi SH; Park CK; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
    Korean J Radiol; 2021 Sep; 22(9):1514-1524. PubMed ID: 34269536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction.
    Bae S; Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Radiology; 2018 Dec; 289(3):797-806. PubMed ID: 30277442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.
    Roux A; Roca P; Edjlali M; Sato K; Zanello M; Dezamis E; Gori P; Lion S; Fleury A; Dhermain F; Meder JF; Chrétien F; Lechapt E; Varlet P; Oppenheim C; Pallud J
    Radiology; 2019 Dec; 293(3):633-643. PubMed ID: 31592732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI Features May Predict Molecular Features of Glioblastoma in
    Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK
    AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.